Table 2. Correlation between plasma levels of MMP-11 and clinicopathological parameters in 330 OSCC patients.
No. of case (%) | MMP-11 level | p value | |
Variables | n = 330 | Mean ± S.D. (ng/mL) | |
Age (years) | |||
<55 | 166 (50.3%) | 15.69±10.12 | 0.592 |
≥55 | 164 (49.7%) | 15.12±9.10 | |
Smoking status | |||
No | 35 (10.6%) | 14.08±9.44 | 0.388 |
Yes | 295 (89.4%) | 15.56±9.64 | |
Drinking status | |||
No | 138 (41.8%) | 14.85±9.45 | 0.377 |
Yes | 192 (58.2%) | 15.80±9.74 | |
Betel nuts chewing | |||
No | 72 (21.8%) | 14.36±9.51 | 0.297 |
Yes | 258 (78.2%) | 15.70±9.65 | |
Cancer location | |||
Buccal mucosa | 120 (36.4%) | 14.17±9.00 | 0.195 |
Tongue | 98 (29.7%) | 15.24±9.61 | |
Gingiva | 49 (14.8%) | 16.60±10.88 | |
Others | 63 (19.1%) | 17.10±9.61 | |
Stage | |||
I+II | 131 (39.7%) | 12.90±8.01 | <0.001 * |
III+IV | 199 (60.3%) | 17.06±10.23 | |
Tumor T status | |||
T1+T2 | 189 (57.3%) | 13.85±8.64 | 0.001 * |
T3+T4 | 141 (42.7%) | 17.48±10.47 | |
Lymph node status | |||
N0 | 201 (60.9%) | 14.25±8.98 | 0.006 * |
N1+N2+N3 | 129 (39.1%) | 17.21±10.32 | |
Metastasis | |||
M0 | 328 (99.4%) | 15.31±9.56 | 0.183 |
M1 | 2 (0.6%) | 30.86±6.65 | |
Cell differentiation | |||
Well differentiated | 35 (10.6%) | 15.36±9.38 | 0.975 |
Moderately or poorly differentiated | 295 (89.4%) | 15.41±9.66 |
*p<0.05.